Literature DB >> 12023273

Second cysteine-rich region of epidermal growth factor receptor contains targeting information for caveolae/rafts.

Montarop Yamabhai1, Richard G W Anderson.   

Abstract

Previous studies have shown that approximately 60% of the epidermal growth factor receptors (EGFRs) in quiescent fibroblasts are concentrated in the caveolae/raft fraction from purified plasma membranes. This high degree of localization suggests the EGFR contains targeting information for lipid domains. We have used mutagenesis to determine that the region of the receptor that controls targeting to caveolae/rafts resides in the juxtamembrane, second cysteine-rich region. A 60-amino acid-long sequence within this region that is continuous with the transmembrane domain was sufficient to target the transmembrane and cytoplasmic tails of both EGFR and the low density lipoprotein receptor to caveolae/rafts. Two N-linked sugars in this segment were not required for proper targeting, although unglycosylated wild-type receptors did not localize properly. We conclude that, in contrast to signals for coated pit localization that are in the cytoplasmic tail, the targeting information for caveolae/rafts is on the extracellular side of the EGFR very close to the membrane.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023273     DOI: 10.1074/jbc.C200277200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.

Authors:  Rennolds S Ostrom; Paul A Insel
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

2.  The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.

Authors:  Sangeeta Adak; Diana DeAndrade; Linda J Pike
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

3.  The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases.

Authors:  Nadia Nour; Gaétan Mayer; John S Mort; Alexandre Salvas; Majambu Mbikay; Charlotte J Morrison; Christopher M Overall; Nabil G Seidah
Journal:  Mol Biol Cell       Date:  2005-08-31       Impact factor: 4.138

4.  Phase coexistence and connectivity in the apical membrane of polarized epithelial cells.

Authors:  Doris Meder; Maria Joao Moreno; Paul Verkade; Winchil L C Vaz; Kai Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

5.  FAPP2, cilium formation, and compartmentalization of the apical membrane in polarized Madin-Darby canine kidney (MDCK) cells.

Authors:  Otilia V Vieira; Katharina Gaus; Paul Verkade; Joachim Fullekrug; Winchil L C Vaz; Kai Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

6.  Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling.

Authors:  Sergio Oddi; Enrico Dainese; Simone Sandiford; Filomena Fezza; Mirko Lanuti; Valerio Chiurchiù; Antonio Totaro; Giuseppina Catanzaro; Daniela Barcaroli; Vincenzo De Laurenzi; Diego Centonze; Somnath Mukhopadhyay; Jana Selent; Allyn C Howlett; Mauro Maccarrone
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 7.  Caveolins in cardioprotection - translatability and mechanisms.

Authors:  Jan M Schilling; David M Roth; Hemal H Patel
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

Review 8.  The challenge of lipid rafts.

Authors:  Linda J Pike
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

Review 9.  Lipid rafts: heterogeneity on the high seas.

Authors:  Linda J Pike
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

10.  Coordinated Mechanosensitivity of Membrane Rafts and Focal Adhesions.

Authors:  Daniela E Fuentes; Peter J Butler
Journal:  Cell Mol Bioeng       Date:  2012-06-01       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.